LFCR
Price
$7.53
Change
-$0.41 (-5.16%)
Updated
Sep 5 closing price
Capitalization
281.68M
26 days until earnings call
TLRY
Price
$1.19
Change
+$0.04 (+3.48%)
Updated
Sep 5 closing price
Capitalization
1.26B
26 days until earnings call
Interact to see
Advertisement

LFCR vs TLRY

Header iconLFCR vs TLRY Comparison
Open Charts LFCR vs TLRYBanner chart's image
Lifecore Biomedical
Price$7.53
Change-$0.41 (-5.16%)
Volume$138.55K
Capitalization281.68M
Tilray Brands
Price$1.19
Change+$0.04 (+3.48%)
Volume$41.19M
Capitalization1.26B
LFCR vs TLRY Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. TLRY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and TLRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LFCR: $7.53 vs. TLRY: $1.19)
Brand notoriety: LFCR: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 109% vs. TLRY: 61%
Market capitalization -- LFCR: $281.68M vs. TLRY: $1.26B
LFCR [@Pharmaceuticals: Generic] is valued at $281.68M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $1.26B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -1.05% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -13.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.26B) has a higher market cap than LFCR($282M). LFCR YTD gains are higher at: 1.346 vs. TLRY (-10.526). LFCR has higher annual earnings (EBITDA): -8.81M vs. TLRY (-2.13B). TLRY has more cash in the bank: 256M vs. LFCR (8.27M). LFCR has less debt than TLRY: LFCR (131M) vs TLRY (329M). TLRY has higher revenues than LFCR: TLRY (821M) vs LFCR (129M).
LFCRTLRYLFCR / TLRY
Capitalization282M1.26B22%
EBITDA-8.81M-2.13B0%
Gain YTD1.346-10.526-13%
P/E Ratio51.23N/A-
Revenue129M821M16%
Total Cash8.27M256M3%
Total Debt131M329M40%
FUNDAMENTALS RATINGS
LFCR vs TLRY: Fundamental Ratings
LFCR
TLRY
OUTLOOK RATING
1..100
382
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4035
P/E GROWTH RATING
1..100
794
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for LFCR (99) in the Industrial Specialties industry. This means that TLRY’s stock grew somewhat faster than LFCR’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's SMR Rating (99) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's Price Growth Rating (35) in the Biotechnology industry is in the same range as LFCR (40) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (7) in the Industrial Specialties industry is significantly better than the same rating for TLRY (94) in the Biotechnology industry. This means that LFCR’s stock grew significantly faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRTLRY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURN16.720.12
+0.72%
Currency Exchange International Corp
ELLH14.00N/A
N/A
Elah Holdings Inc.
JNDOF22.75N/A
N/A
Jins Hldgs Inc.
AXFOY27.24N/A
N/A
Axfood AB
CIIHY35.24-1.77
-4.77%
Citic Securities Co., Ltd.

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-5.16%
NBIX - LFCR
36%
Loosely correlated
+2.64%
SHPH - LFCR
31%
Poorly correlated
-1.17%
TKNO - LFCR
27%
Poorly correlated
+2.83%
TLRY - LFCR
27%
Poorly correlated
+3.48%
ALKS - LFCR
26%
Poorly correlated
+3.53%
More